Sonia M. Martinez

Boadilla Del Monte, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Biobanked Liver Organoids: A Roadmap for Precision Hepatology.

Biobanked Liver Organoids: A Roadmap for Precision Hepatology.

Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: December 17, 2025

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

Journal: The EMBO journal
Published: July 17, 2025

SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis.

SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis.

Journal: Cell death & disease
Published: July 05, 2024

Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits.

Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits.

Journal: Cancer cell
Published: November 10, 2022

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

Journal: EMBO molecular medicine
Published: May 14, 2021

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Journal: EMBO molecular medicine
Published: January 10, 2020

Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases.

Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases.

Journal: Nature cell biology
Published: May 02, 2019

Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer.

Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer.

Journal: Oncogene
Published: March 28, 2019

The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.

The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.

Journal: Nature communications
Published: February 05, 2019

Multiple cancer pathways regulate telomere protection.

Multiple cancer pathways regulate telomere protection.

Journal: EMBO molecular medicine
Published: January 08, 2019

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Journal: EMBO molecular medicine
Published: November 12, 2018

Screening protocol for the identification of modulators by immunofluorescent cell-based assay.

Screening protocol for the identification of modulators by immunofluorescent cell-based assay.

Journal: Chemical biology & drug design
Published: September 18, 2018
Showing 1-12 of 19

Last Updated: 09/26/2026